NLM Logo

Certolizumab Pegol MeSH Descriptor Data 2021


MeSH Heading
Certolizumab Pegol
Tree Number(s)
D05.750.741.125
D12.644.541.500.650.250
D12.776.124.486.485.114.224.060.500
D12.776.124.486.485.680.650.250
D12.776.124.790.651.114.224.060.500
D12.776.124.790.651.680.650.250
D12.776.377.715.548.114.224.200.500
D12.776.377.715.548.680.650.250
Unique ID
D000068582
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000068582
Scope Note
A polyethylene-glycolated Fab' fragment of TUMOR NECROSIS FACTOR antibody that binds specifically to TNF-ALPHA and neutralises it in a dose-dependent manner. It also inhibits the production of lipopolysaccharide-induced TNF-ALPHA and IL-1 BETA and is used to treat RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
Entry Term(s)
CDP 870
CDP870
Cimzia
Pharm Action
Immunosuppressive Agents
Antirheumatic Agents
Registry Number
UMD07X179E
Related Numbers
428863-50-7
See Also
Tumor Necrosis Factor-alpha
Public MeSH Note
2016; CERTILIZUMAB PEGOL was indexed under IMMUNOGLOBULIN FAB FRAGMENTS 2003-2015, POLYETHYLENE GLYCOLS 2003-2015, and under ANTIBODIES, MONOCLONAL, HUMANIZED 2003-2015
History Note
2016 (2003)
Date Established
2016/01/01
Date of Entry
2015/07/10
Revision Date
2017/04/10
Certolizumab Pegol Preferred
Cimzia Narrower
CDP870 Narrower
page delivered in 0.174s